HOME >> BIOLOGY >> NEWS
Toward improved forms of a time-tested cholesterol-fighter

CHICAGO, March 27 New discoveries offer promise for developing drugs that improve on the therapeutic profile of niacin, the inexpensive, time-tested B-vitamin that boosts levels of HDL cholesterol the good cholesterol with the potential to protect people against heart attacks and stroke, scientists reported today.

Graeme Semple, Ph.D., Vice President of Discovery Chemistry at Arena Pharmaceuticals, San Diego, Calif., described new insights into developing drugs that raise HDL via the same mechanism as niacin in a report scheduled for presentation at the 233rd national meeting of the American Chemical Society, being held here this week.

In small doses, niacin is the familiar B-complex vitamin, which helps the body metabolize or breakdown carbohydrates, fats and protein into compounds that the body needs to maintain good health. In the high doses prescribed by a physician, niacin can increase HDL by as much as 35 percent and reduce levels of artery-clogging triglycerides by 50 percent.

Doctors have known since the 1970s that niacin can reduce the risk of heart attacks and strokes, but it has not been prescribed as widely as newer and more costly medications known as statins.

The use of niacin is limited by its side-effects, including a highly uncomfortable skin flushing, which contributes significantly to poor patient compliance, Semple explained. Since currently marketed cholesterol drugs have a more modest HDL-raising activity than niacin, better tolerated HDL-targeted therapies with improved efficacy could provide additional clinical benefits to patients and potentially reduce the risk of heart attack and stroke.

Semple described research toward that goal, including Arenas discovery of a niacin receptor termed GPR109a. It is among a family of so-called G protein-coupled receptors (GPCRs) that have long been considered among scientists as good targets for the development of new drugs.

Molecules terme
'"/>


27-Mar-2007


Page: 1 2

Related biology news :

1. Toward more effective paleolgenetic analysis
2. Dengue and other hemorrhagic fevers: Towards a first potential treatment
3. Towards predicting late-stage radiation toxicity
4. Toward a less expensive, more convenient treatment of Gauchers disease
5. Towards the mechanism of cell respiration
6. Towards a unified model of transcription termination
7. Towards a cheap and easy way to monitor HIV/AIDS
8. Towards targeted lung cancer treatment
9. Toward a better understanding of taste and smell impairments
10. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
11. Gene expression pattern could lead to improved treatment of pediatric septic shock

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... ... December 10, 2018 , ... Today, RoosterBio Inc. and Tissue ... of accelerating the development of the Regenerative Medicine field. This alliance will ... around human umbilical cord perivascular cells (HUCPVCs). Together, it is anticipated that ...
(Date:12/5/2018)... British Columbia (PRWEB) , ... December 05, 2018 ... ... The Royal Society of Medicine’s Photodynamic Therapy symposium 2018, London, England. The 2018 ... addressed the scientific basis of PDT and its benefits in clinical practice across ...
(Date:12/5/2018)... (PRWEB) , ... December 04, 2018 , ... ... sciences and diagnostics companies, announces the placement of Michael Mercer at Karius, Inc. ... business strategy, Mr. Mercer will be based at Karius' headquarters in Redwood City, ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... December 12, 2018 , ... RURO, Inc., a leading provider ... ML (Machine Learning) addition for its Limfinity® 7 framework. , Limfinity® ML ... the module, trained models make predictions based on user inputs; the result of ...
(Date:12/5/2018)... ... December 05, 2018 , ... Leading authority on how ... how-to guide with his “The Referral Playbook: How to Increase Sales with Proven ... book proceeds will go to the Alzheimer’s Foundation of America (AFA). , Itzkowich ...
(Date:11/29/2018)... ... ... RAGS, today announced the closing of a $1.5 million Second Seed round investment. ... board member Jeremy Andrus, CEO of Traeger Grills, as well as James Ho of ... to accelerate its growth and expand the product line. RAGS has now raised a ...
(Date:11/20/2018)... ... November 19, 2018 , ... ... the release of the Chinese translation of Best Practices: Recommendations for Repositories, Fourth ... practice-changing publication aimed at advancing the science of biobanking to meet the needs ...
Breaking Biology Technology:
Cached News: